Updates • Announcements • Deadlines

Announcements • Milestones • Notices

Latest Updates

Stay informed with curated announcements for EECCTM 2027—program milestones, advisory board and featured leader announcements, participation notices, and important congress updates.

Updates are posted as confirmations are finalised. Please check back regularly.

Updates Feed

Filter by category or search by keywords (e.g., “program”, “deadline”, “speaker”, “visa”, “roundtable”).

Admin tip: duplicate an “Update card” and change data-category, data-keywords, and the <time> label.
Program
In progress

Program structure in development

The EECCTM 2027 program is being finalised around executive tracks, curated panels, strategic roundtables, and case-based translational discussions. Updates will be posted as chairs, session objectives, and speaker confirmations are completed.

Speakers
Invitations ongoing

Speaker invitations in progress

Invitations are being extended to senior clinical leaders, translational innovators, trialists, and biotech/medtech executives. Confirmed speakers will be published once final approvals and bios are received.

Advisory Board
Announced

Advisory Board announced

The EECCTM 2027 Advisory Board has been announced, bringing together senior leaders whose work reflects the scientific, clinical, and strategic priorities of contemporary clinical and translational medicine. The board supports the congress with broad expertise across translational strategy, precision medicine, clinical development, biomarkers, implementation, and evidence-driven innovation.

Featured Leaders
Published

Featured Leaders page now live

The Featured Leaders page is now live and presents the current leader lineup for EECCTM 2027. The page highlights leaders whose work aligns with the congress scope across clinical and translational medicine, including precision medicine, neuroscience, biomarker-led innovation, bioethics, digital health, translational science, and evidence-led implementation.

Deadlines
Rolling review

Participation windows are category-specific

Participation timelines may differ for attendees, speakers, sponsors, and strategic partners. We recommend submitting early for best consideration and planning alignment.

Notice
Subject to refinement

Program refinements may occur

Themes, session formats, and sequencing may be refined to maintain executive relevance, speaker availability, and agenda coherence. Major changes will be communicated here and on the relevant pages.

Want to stay updated?

For the latest confirmations on agenda milestones, speakers, deadlines, and participation notices, contact our team or send a quick request for updates.

Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Direct email

Request updates via:

participation@executivecongresses.com
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK